{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T10:34:07Z","timestamp":1793097247822,"version":"4.5.0"},"reference-count":28,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Immunocytochemistry (ICC) is central to diagnostic cytopathology, yet achieving consistent staining quality remains challenging owing to technical complexity and limited standardization. External quality assessment (EQA) programs provide an objective framework for benchmarking ICC performance across laboratories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To analyze performance trends, technical variables, and participant self-assessment in the United Kingdom National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation (UK NEQAS ICC &amp; ISH) cytopathology module during a 10-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Data from 41 EQA runs (June 2014\u2013May 2024) involving 140 laboratories were analyzed. ICC quality on UK NEQAS\u2013provided cytology slides and participant in-house control slides was evaluated by expert assessors using a predefined scoring system (range, 0\u201320; satisfactory \u226513). Expert scores, participant self-assessment, and assessors\u2019 comments were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>\n                      Of 14\u2009639 slides assessed, 90.3% achieved satisfactory staining quality, with significant improvement over time. Cell blocks showed higher mean scores and fewer suboptimal results than cytospins (15.77 versus 15.19;\n                      <jats:italic>P<\/jats:italic>\n                      &lt; .001). Fixation influenced performance on in-house controls: methanol-fixed preparations had higher mean scores than formalin-fixed samples (16.36 versus 16.05;\n                      <jats:italic>P<\/jats:italic>\n                      = .003) but a higher suboptimal rate, while acetone- and ethanol-fixed samples performed less well. Inappropriate control selection was a major cause of suboptimal results. Participant self-assessment correlated weakly with expert evaluation (\n                      <jats:italic>r<\/jats:italic>\n                      = .30) and tended to overestimate performance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>ICC performance in cytology is generally satisfactory and improving. While cell blocks offer the most robust standardization, optimized methanol fixation represents a viable alternative for non\u2013cell block samples. The discordance between participant self-assessment and expert review highlights the continuing value of EQA in identifying quality gaps and guiding improvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2025-0617-oa","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:59:56Z","timestamp":1779242396000},"page":"851-859","source":"Crossref","is-referenced-by-count":0,"title":["External Quality Assessment of Immunocytochemistry on Cytology Samples: A 10-Year Analysis of the United Kingdom National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation Cytopathology Module"],"prefix":"10.5858","volume":"150","author":[{"given":"R\u00faben Rodrigues","family":"Roque","sequence":"first","affiliation":[{"name":"Servi\u00e7o de Anatomia Patol\u00f3gica, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal (Roque, F\u00e9lix)"},{"name":"Escola Superior de Sa\u00fade de Lisboa, Polytechnic University of Lisbon, Lisbon, Portugal (Roque)"},{"name":"Escola Superior de Sa\u00fade de Lisboa, Polytechnic University of Lisbon, Lisbon, Portugal (Roque)"},{"name":"NOVA National School of Public Health (Roque) and NOVA Medical School (F\u00e9lix), Universidade NOVA de Lisboa, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Srebotnik Kirbis","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Faculty of Medicine, University of Ljubljana, Slovenia (Srebotnik Kirbis)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Parry","sequence":"additional","affiliation":[{"name":"United Kingdom National External Quality Assessment Scheme for Immunocytochemistry & In-Situ Hybridisation, London, United Kingdom (Parry)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"F\u00e9lix","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Anatomia Patol\u00f3gica, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal (Roque, F\u00e9lix)"},{"name":"NOVA National School of Public Health (Roque) and NOVA Medical School (F\u00e9lix), Universidade NOVA de Lisboa, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"6","key":"i1543-2165-150-11-851-b01","series-title":"Arch Pathol Lab Med","first-page":"e111","article-title":"Principles of analytic validation of immunohistochemical assays: guideline update","volume":"148","author":"Goldsmith","year":"2024","unstructured":"Goldsmith JD,\nTroxell ML,\nRoy-Chowdhuri S, et al. Principles of analytic validation of immunohistochemical assays: guideline update. Arch Pathol Lab Med. 2024;148(6):e111\u2013e153. doi:10.5858\/arpa.2023-0483-CP"},{"issue":"1","key":"i1543-2165-150-11-851-b02","series-title":"Appl Immunohistochem Mol Morphol","first-page":"4","article-title":"Evolution of quality assurance for clinical immunohistochemistry in the era of precision medicine, part 1: fit-for-purpose approach to classification of clinical immunohistochemistry biomarkers","volume":"25","author":"Cheung","year":"2017","unstructured":"Cheung CC,\nD\u2019Arrigo C,\nDietel M, et al. Evolution of quality assurance for clinical immunohistochemistry in the era of precision medicine, part 1: fit-for-purpose approach to classification of clinical immunohistochemistry biomarkers. Appl Immunohistochem Mol Morphol. 2017;25(1):4\u201311. doi:10.1097\/PAI.0000000000000451"},{"issue":"3","key":"i1543-2165-150-11-851-b03","series-title":"Appl Immunohistochem Mol Morphol","first-page":"151","article-title":"Evolution of quality assurance for clinical immunohistochemistry in the era of precision medicine, part 3: technical validation of immunohistochemistry (IHC) assays in clinical IHC laboratories","volume":"25","author":"Torlakovic","year":"2017","unstructured":"Torlakovic EE,\nCheung CC,\nD\u2019Arrigo C, et al. Evolution of quality assurance for clinical immunohistochemistry in the era of precision medicine, part 3: technical validation of immunohistochemistry (IHC) assays in clinical IHC laboratories. Appl Immunohistochem Mol Morphol. 2017;25(3):151\u2013159. doi:10.1097\/PAI.0000000000000470"},{"issue":"1","key":"i1543-2165-150-11-851-b04","series-title":"Acta Cytol","first-page":"51","article-title":"State of the art and science of immunocytochemistry","volume":"69","author":"Srebotnik Kirbis","year":"2025","unstructured":"Srebotnik Kirbis I. State of the art and science of immunocytochemistry. Acta Cytol. 2025;69(1):51\u201359. doi:10.1159\/000539634"},{"issue":"3","key":"i1543-2165-150-11-851-b05","series-title":"Am J Clin Pathol","first-page":"354","article-title":"Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee\/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests","volume":"133","author":"Torlakovic","year":"2010","unstructured":"Torlakovic EE,\nRiddell R,\nBanerjee D, et al. Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee\/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests. Am J Clin Pathol. 2010;133(3):354\u2013365. doi:10.1309\/AJCPDYZ1XMF4HJWK"},{"key":"i1543-2165-150-11-851-b06","article-title":"Medical Laboratories\u2014Requirements for Quality and Competence","author":"International Organization for Standardization","year":"2022","unstructured":"International Organization for Standardization. Medical Laboratories\u2014Requirements for Quality and Competence. ISO 15189:2022. International Organization for Standardization; 2022."},{"issue":"9","key":"i1543-2165-150-11-851-b07","series-title":"Cancer Cytopathol","first-page":"547","article-title":"The updated College of American Pathologists principles of analytic validation of immunohistochemical assays: a step forward for cytopathology","volume":"132","author":"Roy\u2010Chowdhuri","year":"2024","unstructured":"Roy\u2010Chowdhuri S. The updated College of American Pathologists principles of analytic validation of immunohistochemical assays: a step forward for cytopathology. Cancer Cytopathol. 2024;132(9):547\u2013548. doi:10.1002\/cncy.22818"},{"issue":"15","key":"i1543-2165-150-11-851-b08","series-title":"Cancers (Basel)","first-page":"3686","article-title":"The significance of external quality assessment schemes for molecular testing in clinical laboratories","volume":"14","author":"Laudus","year":"2022","unstructured":"Laudus N,\nNijs L,\nNauwelaers I,\nDequeker EMC. The significance of external quality assessment schemes for molecular testing in clinical laboratories. Cancers (Basel). 2022;14(15):3686. doi:10.3390\/cancers14153686"},{"issue":"1","key":"i1543-2165-150-11-851-b09","series-title":"Cancer","first-page":"68","article-title":"Immunocytochemistry in the differential diagnosis of serous effusions","volume":"93","author":"Lozano","year":"2001","unstructured":"Lozano MD,\nPanizo A,\nToledo GR,\nSola JJ,\nPardo-Mind\u00e1n J. Immunocytochemistry in the differential diagnosis of serous effusions. Cancer. 2001;93(1):68\u201372."},{"issue":"10","key":"i1543-2165-150-11-851-b10","series-title":"Cancer Cytopathol","first-page":"757","article-title":"Immunocytochemistry practices in European cytopathology laboratories\u2014review of European Federation of Cytology Societies (EFCS) online survey results with best practice recommendations","volume":"128","author":"Srebotnik Kirbi\u0161","year":"2020","unstructured":"Srebotnik Kirbi\u0161 I,\nRodrigues Roque R,\nBongiovanni M,\nStrojan Fle\u017ear M,\nCochand\u2010Priollet B. Immunocytochemistry practices in European cytopathology laboratories\u2014review of European Federation of Cytology Societies (EFCS) online survey results with best practice recommendations. Cancer Cytopathol. 2020;128(10):757\u2013766. doi:10.1002\/cncy.22311"},{"issue":"5","key":"i1543-2165-150-11-851-b11","series-title":"Biotech Histochem","first-page":"331","article-title":"External quality assessment for immunohistochemistry: experiences from NordiQC","volume":"90","author":"Nielsen","year":"2015","unstructured":"Nielsen S. External quality assessment for immunohistochemistry: experiences from NordiQC. Biotech Histochem. 2015;90(5):331\u2013340. doi:10.3109\/10520295.2015.1033462"},{"issue":"11","key":"i1543-2165-150-11-851-b12","series-title":"Arch Pathol Lab Med","first-page":"1229","article-title":"Immunohistochemistry should be regulated as an assay","volume":"147","author":"Magnani","year":"2023","unstructured":"Magnani B,\nTaylor CR. Immunohistochemistry should be regulated as an assay. Arch Pathol Lab Med. 2023;147(11):1229\u20131231. doi:10.5858\/arpa.2023-0048-ED"},{"issue":"1","key":"i1543-2165-150-11-851-b13","series-title":"Virchows Arch","first-page":"19","article-title":"Proficiency testing in immunohistochemistry\u2014experiences from Nordic Immunohistochemical Quality Control (NordiQC)","volume":"468","author":"Vyberg","year":"2016","unstructured":"Vyberg M,\nNielsen S. Proficiency testing in immunohistochemistry\u2014experiences from Nordic Immunohistochemical Quality Control (NordiQC). Virchows Arch. 2016;468(1):19\u201329. doi:10.1007\/s00428-015-1829-1"},{"issue":"1","key":"i1543-2165-150-11-851-b14","series-title":"Acta Cytol","first-page":"84","article-title":"External quality assessment in diagnostic cytopathology: current programs, challenges, and perspectives","volume":"70","author":"Srebotnik Kirbis","year":"2026","unstructured":"Srebotnik Kirbis I,\nStrojan Fle\u017ear M. External quality assessment in diagnostic cytopathology: current programs, challenges, and perspectives. Acta Cytol. 2026;70(1):84\u201390. doi:10.1159\/000546537"},{"issue":"4","key":"i1543-2165-150-11-851-b15","series-title":"Cytopathology","first-page":"230","article-title":"External quality control for immunocytochemistry on cytology samples: a review of UK NEQAS ICC (cytology module) results","volume":"22","author":"Kirbis","year":"2011","unstructured":"Kirbis IS,\nMaxwell P,\nFle\u017ear MS,\nMiller K,\nIbrahim M. External quality control for immunocytochemistry on cytology samples: a review of UK NEQAS ICC (cytology module) results. Cytopathology. 2011;22(4):230\u2013237. doi:10.1111\/j.1365-2303.2011.00867.x"},{"issue":"2","key":"i1543-2165-150-11-851-b16","series-title":"J Clin Pathol","first-page":"141","article-title":"Use of alcohol fixed cytospins protected by 10% polyethylene glycol in immunocytology external quality assurance","volume":"52","author":"Maxwell","year":"1999","unstructured":"Maxwell P,\nPatterson AH,\nJamison J,\nMiller K,\nAnderson N. Use of alcohol fixed cytospins protected by 10% polyethylene glycol in immunocytology external quality assurance. J Clin Pathol. 1999;52(2):141\u2013144. doi:10.1136\/JCP.52.2.141"},{"issue":"1","key":"i1543-2165-150-11-851-b17","series-title":"Cytopathology","first-page":"84","article-title":"Preservation of biomarkers immunoreactivity on cytospins protected with polyethylene glycol","volume":"32","author":"Srebotnik Kirbis","year":"2021","unstructured":"Srebotnik Kirbis I,\nPra\u00e7a MJ,\nRoque RR,\nKo\u0161uta T,\nSaudade A,\nStrojan Flezar M. Preservation of biomarkers immunoreactivity on cytospins protected with polyethylene glycol. Cytopathology. 2021;32(1):84\u201391. doi:10.1111\/cyt.12913"},{"issue":"2","key":"i1543-2165-150-11-851-b18","series-title":"Cancer Cytopathol","first-page":"e70072","article-title":"Validation of on\u2010slide immunocytochemistry controls prepared from long\u2010term preserved prefixed cell suspensions","volume":"134","author":"Roque","year":"2026","unstructured":"Roque RR,\nSrebotnik Kirbi\u0161 I,\nPinheiro CSC, et al. Validation of on\u2010slide immunocytochemistry controls prepared from long\u2010term preserved prefixed cell suspensions. Cancer Cytopathol. 2026;134(2):e70072. doi:10.1002\/cncy.70072"},{"key":"i1543-2165-150-11-851-b19","article-title":"UK NEQAS for Immunocytochemistry & In-Situ Hybridisation Participants\u2019 Manual 2024-2025","author":"Dodson","year":"2024","unstructured":"Dodson A,\nParry S. UK NEQAS for Immunocytochemistry & In-Situ Hybridisation Participants\u2019 Manual 2024-2025. UK NEQAS; 2024."},{"issue":"1","key":"i1543-2165-150-11-851-b20","series-title":"Acta Cytol","first-page":"60","article-title":"Quality assurance in immunocytochemistry: a review and practical considerations","volume":"69","author":"Lozano","year":"2025","unstructured":"Lozano MD,\nRobledano R,\nArgueta A. Quality assurance in immunocytochemistry: a review and practical considerations. Acta Cytol. 2025;69(1):60\u201368. doi:10.1159\/000540532"},{"issue":"2","key":"i1543-2165-150-11-851-b21","series-title":"Cytopathology","first-page":"88","article-title":"Optimization and validation of immunocytochemical detection of oestrogen receptors on cytospins prepared from fine needle aspiration (FNA) samples of breast cancer","volume":"26","author":"Srebotnik Kirbi\u0161","year":"2015","unstructured":"Srebotnik Kirbi\u0161 I,\nUs Kra\u0161ovec M,\nPoga\u010dnik A,\nStrojan Fle\u017ear M. Optimization and validation of immunocytochemical detection of oestrogen receptors on cytospins prepared from fine needle aspiration (FNA) samples of breast cancer. Cytopathology. 2015;26(2):88\u201398. doi:10.1111\/cyt.12143"},{"issue":"1","key":"i1543-2165-150-11-851-b22","series-title":"Cytopathology","first-page":"38","article-title":"Optimization of immunocytochemistry in cytology: comparison of two protocols for fixation and preservation on cytospin and smear preparations","volume":"26","author":"Pinheiro","year":"2015","unstructured":"Pinheiro C,\nRoque R,\nAdriano A, et al. Optimization of immunocytochemistry in cytology: comparison of two protocols for fixation and preservation on cytospin and smear preparations. Cytopathology. 2015;26(1):38\u201343. doi:10.1111\/cyt.12156"},{"issue":"1","key":"i1543-2165-150-11-851-b23","series-title":"Diagn Cytopathol","first-page":"59","article-title":"Molecular\/biomarker testing in lung cytology: a practical approach","volume":"51","author":"Schmitt","year":"2023","unstructured":"Schmitt F,\nLozano MD. Molecular\/biomarker testing in lung cytology: a practical approach. Diagn Cytopathol. 2023;51(1):59\u201367. doi:10.1002\/dc.25054"},{"issue":"1","key":"i1543-2165-150-11-851-b24","series-title":"Acta Cytol","first-page":"69","article-title":"Diagnostic and predictive immunocytochemistry in lung cancer","volume":"69","author":"Jain","year":"2025","unstructured":"Jain D,\nSatapathy S,\nBubendorf L. Diagnostic and predictive immunocytochemistry in lung cancer. Acta Cytol. 2025;69(1):69\u201376. doi:10.1159\/000541478"},{"issue":"1","key":"i1543-2165-150-11-851-b25","series-title":"Acta Cytol","first-page":"44","article-title":"Integrated on-slide positive controls for immunocytochemistry on cytology slides","volume":"69","author":"Srebotnik Kirbi\u0161","year":"2025","unstructured":"Srebotnik Kirbi\u0161 I,\nRoque RR,\nStrojan Fle\u017ear M. Integrated on-slide positive controls for immunocytochemistry on cytology slides. Acta Cytol. 2025;69(1):44\u201350. doi:10.1159\/000540413"},{"issue":"4","key":"i1543-2165-150-11-851-b26","series-title":"Cytopathology","first-page":"238","article-title":"Immunocytochemistry in Europe: results of the European Federation of Cytology Societies (EFCS) inquiry","volume":"22","author":"Schmitt","year":"2011","unstructured":"Schmitt F,\nCochand-Priollet B,\nToetsch M,\nDavidson B,\nBondi A,\nVielh P. Immunocytochemistry in Europe: results of the European Federation of Cytology Societies (EFCS) inquiry. Cytopathology. 2011;22(4):238\u2013242. doi:10.1111\/j.1365-2303.2011.00885.x"},{"issue":"9","key":"i1543-2165-150-11-851-b27","series-title":"Arch Pathol Lab Med","first-page":"1167","article-title":"Immunohistochemistry practices of cytopathology laboratories: a survey of participants in the College of American Pathologists Nongynecologic Cytopathology Education Program","volume":"138","author":"Fischer","year":"2014","unstructured":"Fischer AH,\nSchwartz MR,\nMoriarty AT, et al. Immunohistochemistry practices of cytopathology laboratories: a survey of participants in the College of American Pathologists Nongynecologic Cytopathology Education Program. Arch Pathol Lab Med. 2014;138(9):1167\u20131172. doi:10.5858\/arpa.2013-0259-CP"},{"issue":"12","key":"i1543-2165-150-11-851-b28","series-title":"Arch Pathol Lab Med","first-page":"1318","article-title":"The state of cell blocks and ancillary testing: past, present, and future","volume":"140","author":"Saqi","year":"2016","unstructured":"Saqi A. The state of cell blocks and ancillary testing: past, present, and future. Arch Pathol Lab Med. 2016;140(12):1318\u20131322. doi:10.5858\/arpa.2016-0125-RA"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/11\/article-p851.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/11\/article-p851.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/11\/article-p851.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:53:01Z","timestamp":1793094781000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/11\/article-p851.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2025-0617-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]}}}